CARM (carismatx.com) Sof foyda

CARM (carismatx.com) - kompaniyaning tovar belgisi

Carisma Therapeutics (CARM) saraton o'smalariga qarshi kurashish uchun innovatsion CAR-makrofaglarni yaratishga e'tibor qaratadi. Kompaniyaning sof foyda darajasi joriy rivojlanish dinamikasini namoyish etadi, bunda -0.05 so'nggi metrika darajasini ifodalaydi. Qattiq neoplazmalarni yorib o'tishning inqilobiy usullari yangi terapevtik ufqlarni ochmoqda, optimallashtirilgan biomaterial yetkazib berish kanallari esa ilmiy tadqiqotlarning barqarorligini ta'minlaydi.

CARM (Carisma Therapeutics) Sof foyda tarixi 28.04.2023dan 25.10.2025gacha

carismatx.com (CARM) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Carisma Therapeutics Inc.|CARM - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi CARM|CARM - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Carisma Therapeutics|CARM - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi carismatx.com|CARM - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Carisma Therapeutics|CARM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Carisma Therapeutics Inc.|CARM - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar CARM|CARM - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Carisma Therapeutics|Shoshilinch likvidlik carismatx.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CARM - Sof foyda
Kompaniyaning jamlanma tahlili:Carisma Therapeutics
Carisma Therapeutics Inc asosiy tovari

Kapitalni tebranishlardan himoya qilish uchun investorlarning tizimli daromadni fundamental baholashni buzishi mumkin bo'lgan bir martalik anomaliyalardan ajratishi juda muhimdir. Carisma Therapeutics (CARM) CAR-M formulalarini ichki ishlab chiqishdan foydalangan holda ishlab chiqarishni autsorsing qilgani sababli, kompaniyaning foyda tarixi real operatsion samaradorlikni tahlil qilish uchun asosiy vosita bo'lib xizmat qiladi, bu esa ushbu grafik dinamikasiga biznes barqarorligini aniqlash va mahalliy pasayishlar paytida aktivlarning asossiz muzlatilishining oldini olish imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|Intrexon - Sof foyda|Pharming Corp (PHAR) - Sof daromad|NKTR: Sof foyda|upstreambio.com (UPB) - Sof foyda|Kompaniyaning sof foydasi Zenas Biopharma|IMNM: Yakuniy foyda|Sof foyda GOSS|Sof moliyaviy natija KalVista Corp|Kompaniyaning sof foydasi Septerna Inc SEPN|Sof moliyaviy natija pieris.com (PVLA)|SVRA - Kompaniyaning sof foydasi|Rigel Pharma (RIGL) - Sof daromad|ANAB: Sof foyda|Astria Corp (ATXS) - Sof foyda|Sof daromad ENGN|RAPT: Yakuniy foyda|Sof daromad JBIO (Aerovate Therapeutics Inc)|Soliqlar to‘langandan keyingi foyda ACRS|Sof foyda KYTX (Kyverna)|Yakuniy foyda TLSA|Cabaletta Bio, Inc. - Sof foyda|Kompaniyaning sof daromadi ventyxbio.com|Theratechnologies (THTX) - Kompaniyaning sof foydasi|Avalo Therapeutics, Inc. - Yakuniy foyda|ELDN (Eledon) - Sof foyda|Sof foyda Agenus, Inc|Kompaniyaning sof foydasi Climb Bio Inc (CLYM)|ZURA: Soliqdan keyingi foyda|Sof foyda ATYR (aTyr Pharma)|Adagene Inc (ADAG) - Kompaniyaning sof daromadi|IMA: Sof daromad|STTK - Sof foyda|EQ (equilliumbio.com) - Sof daromad|CNTB: Soliqlar to‘langandan keyingi foyda|IMUX (Immunic Therapeutics) - Sof foyda|Atara Biotherapeutics Inc (ATRA) - Sof moliyaviy natija|Sof foyda IFRX|Sof daromad X4 Pharmaceuticals, Inc XFOR|Kompaniyaning sof foydasi Adicet Bio, Inc. ACET|Sof moliyaviy natija Celularity Inc (CELU)|INmune Bio - Sof foyda|Barinthus Biotherapeutics PLC (BRNS) - Sof daromad|KZR: Sof foyda|SAB Biotherapeutics Inc (SABS) - Sof foyda|Kompaniyaning sof foydasi Akari Therapeutics|ENLV: Yakuniy foyda|Kompaniyaning sof foydasi Q32 Bio Inc. (QTTB)|Sof daromad GeoVax Labs GOVX|Kompaniyaning sof foydasi Edesa EDSA|IBIO (iBio Corporation) - Soliqdan keyingi foyda|XTL Biopharmaceuticals - Sof foyda|Yakuniy foyda BOLT (Bolt Biotherapeutics)|HCWB: Sof foyda|Aptevo Therapeutics Inc. (APVO) - Sof foyda|Kompaniyaning sof foydasi AIM ImmunoTech|ADTX: Yakuniy foyda|Kompaniyaning sof foydasi GRI Bio, Inc. (GRI)|Sof daromad xortx.com XRTX|Sof foyda HIND (Vyome Holdings)|Sof foyda Revelation Biosciences Inc REVB|INDP: Sof daromad|Yakuniy foyda SCNI (BiondVax Pharmaceuticals)|CALI: Sof foyda|AFMD - Sof moliyaviy natija|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Kompaniyaning sof foydasi IGM Biosciences, Inc. (IGMS)|Sof daromad iTeos Pharma ITOS|Ocean Biomedical, Inc. - Sof daromad|Sof foyda tcbiopharm.com TCBP|THRD - Kompaniyaning sof foydasi